Everything about MBL77
gene in patients relapsing following procedure Together with the BCL2 antagonist venetoclax. 66 Resistance to these agents is linked to these mutations in about 70% of conditions, although they are often subclonal and their unique position triggering resistance has to be demonstrated.Genetic susceptibility mechanisms. Most susceptibility loci map t